Short term catalysts30 Jan 2026 13:51
Someone wanted catalyst details. In no particular order, value, timing or priority.
News on talks with Haleon re appointing sub distributor.
China / APAC partner, talks started last year.
US patent news.
Eroxon Intense HUT study (200 person to inform commercial direction) He will have had the raw data and been in discussions for a couple of months. Doesn't have to release it until it is finalised.
News of divestment plans, CBD100, TPR100,200, Eroxons? WSD? He has allocated legal expenses to explore so it's not just speculation.
Coopers review outcome, Haleon adjusted for key learnings months ago, Coopers are lagging here.
WSD HUT study.
Full strategic review, Duggan seems to be making sure of negotiations and future direction before he announces, by having already talked to the other parties concerned.
Bringing the condoms back and packaging with eroxon.
Revised packaging rollout to increase shelf space exposure, ie 8 pack, Haleon trialling.
Duggan has previously stated he is focused on China because it can move the needle, the Dec patent news was helpful in that regard.
Probably missed some as I wasn't trawling the fundraise document again.